Takeda signs $882m rare disease alliance with Oxford biotech EvoxEvox Therapeutics is the second UK biotech to sign a big deal with a pharma giant this week, Share XTakeda signs $882m rare disease alliance with Oxford biotech Evoxhttps://pharmaphorum.com/news/takeda-signs-882m-rare-disease-alliance-with-oxford-biotech-evox/
Google Ventures leads $45.4m investment in UK exosome biotech EvoxGoogle Ventures and US healthcare specialist Redmile were among a group of investors supporting a £35.5 million funding Share XGoogle Ventures leads $45.4m investment in UK exosome biotech Evoxhttps://pharmaphorum.com/news/google-ventures-leads-45-4m-investment-in-uk-exosome-biotech-evox/
